Prevention & care
Medication reconciliation: comparing medicine lists and resolving unintended discrepancies
On this page
Medication reconciliation compares a person’s current medicine regimen with orders at admission, transfer or discharge to identify discrepancies. Differences are discussed with the prescriber and corrected when appropriate. It is more than copying a list: the process asks whether a change is intended, accurately documented and communicated to the next person providing care.[1]
Different lists can describe different moments
| Category | Meaning | Important boundary |
|---|---|---|
| Medication history | What the person used before the encounter | May require patient, caregiver and pharmacy confirmation[3] |
| Current care orders | What is ordered in the present setting | Some differences from home use are intentional[3] |
| Discharge list | The intended regimen after leaving care | Changes should be explained and sent to the next provider[3] |
Names alone are not a complete medicine record
FDA recommends recording medicine name, strength, purpose and instructions, together with allergies and emergency contacts. Include nonprescription medicines, vitamins and supplements. Bring uncertainty about actual use to the professional’s attention. Paper, a phone image or an app can work if the record is maintained and available. Current information matters more than format.[4]
A discrepancy does not always mean an error
AHRQ’s appendix explicitly distinguishes purposeful changes based on current clinical status or formulary from unintended omissions, additions or changes. A medicine temporarily held in hospital may need a documented decision later. Admission, internal transfer and discharge are therefore distinct checkpoints. Patients should ask which list describes the next stage and why an item changed, rather than assuming the oldest bottle or the newest screen must always be the correct instruction.[3]
Ask about the pharmacy handoff before leaving hospital
An England example is Guy's and St Thomas' discharge medicines service. With your agreement, the hospital sends a discharge summary to your nominated community pharmacy. The pharmacist arranges a conversation about new or changed medicines, their purposes, common side effects and safe use, working alongside the general practitioner. Ask the hospital pharmacy team about the referral and which pharmacy will receive it. This is a practical support route, not a guarantee that every local service has identical arrangements.[9]
Evidence & uncertainty
AHRQ’s digital-health explanation treats reconciliation as an organized clinical process, with different implementation approaches. Technology can help gather and share information, but a populated electronic list is not automatically accurate. The process needs reliable history, clinical interpretation and communication rather than assuming that a completed checkbox settles every medicine issue.[2]
Selected-source overview · Independent review pendingPublished questions
Is reconciliation just writing down medicine names?
Selected-source overview · Independent review pending. Read the evidence context.
No. AHRQ defines it as comparing the current regimen with care orders and resolving discrepancies with the prescriber. A list is an input to that process. The intended changes and their communication also matter.[1]
Evidence behind this answer
- MATCH toolkit introduction
agency or professional medicine guidance · Date not stated
Selected relevant original official guidance passages inspected · Definition; comparison and prescriber resolution
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should supplements and nonprescription products be listed?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. FDA includes prescription medicines, OTC products, vitamins and supplements, with strength, purpose and instructions. Allergies and emergency contacts also help. Keep the record current and share it with the professionals providing care.[4]
Evidence behind this answer
- Create and keep a medication list for your health
agency or professional medicine guidance · Date not stated
Selected relevant original official guidance passages inspected · Record fields; supplements; formats; updating and sharing
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a different discharge list always mean a mistake?
Selected-source overview · Independent review pending. Read the evidence context.
No. Changes can be intentional because the clinical situation changed. AHRQ recommends comparing the lists, documenting the intended regimen and explaining additions or deletions. Unclear differences should be resolved with the responsible team.[3]
Evidence behind this answer
- Medication reconciliation appendix
agency or professional medicine guidance · Date not stated
Selected relevant original official guidance passages inspected · History, intentional changes, transfer and discharge
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can an electronic medicine list still be wrong?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. AHRQ emphasizes confirmation, shared access and updates as reliable information arrives. An electronic format does not establish accuracy by itself. Ask whether the current regimen and source of each change were checked.[5]
Evidence behind this answer
- Designing the medication reconciliation process
agency or professional medicine guidance · Date not stated
Selected relevant original official guidance passages inspected · Shared list; roles; verification and time-stamped changes
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can a medicine-list conversation reveal duplicate brand and generic use?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. AHRQ identifies that as one problem a collaboratively created list can uncover. Bring the actual products and explain use. The team should resolve suspected duplication rather than the patient independently removing prescribed treatment.[6]
Evidence behind this answer
- Create a safe medicine list together
agency or professional medicine guidance · Date not stated
Selected relevant original official guidance passages inspected · Collaborative list; duplicate use, outdated prescriptions and supplements
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does reconciliation guarantee fewer readmissions?
Selected-source overview · Independent review pending. Read the evidence context.
No. The 2018 Cochrane review found uncertainty in several outcomes, including hospitalization measures. A useful safety process and a proven clinical-outcome improvement are different claims. Evidence depends on the intervention, setting and measured endpoint.[7]
Evidence behind this answer
- Impact of medication reconciliation for improving transitions of care
systematic review · 2018
Original review summary and abstract inspected; no independent full-text appraisal · Original summary and abstract: trials, outcomes and certainty
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
How can I arrange pharmacy help with medicines changed in hospital?
Selected-source overview · Independent review pending. Read the evidence context.
In this England example, ask the hospital pharmacy team about its discharge medicines service. With agreement, information goes to the nominated community pharmacy, which arranges a medicines conversation. Check the actual local handoff.[9]
Evidence behind this answer
- Discharge medicines service
official local patient service information · Date not stated
original patient information read. Whole patient-information body, enrollment, sharing, contact, review dates. No independent full evidence appraisal or qualified review completed. · Whole patient-information body, enrollment, sharing, contact, review dates.
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Patients and caregivers contribute information clinicians may miss
AHRQ’s primary-care guide describes building a safe medicine list together. This can reveal duplicate brand and generic use, outdated prescriptions or interacting supplements. The discussion should allow a person to explain actual use and difficulties without treating every difference as deliberate nonadherence. A caregiver can supply context when memory, language or illness limits communication. The aim is a reconciled understanding and documented plan, not a patient’s unsupported choice to discontinue items that look redundant.[6]
Improving lists and improving outcomes are different endpoints
A 2018 Cochrane review included 25 randomized trials involving 6,995 participants, mostly in hospital-related settings. It found a pooled reduction in having at least one discrepancy, but graded that evidence very low certainty, leaving the effect uncertain. Clinical outcomes such as adverse events and readmission had differing evidence quality and imprecise findings. These results distinguish a plausible safety process from a guaranteed reduction in hospitalization. This dated review is not an exhaustive appraisal of subsequent research.[7]
A safety process depends on its surrounding system
WHO’s 2019 technical-report overview identifies transitions of care as a medication-safety priority. It highlights structured processes, workforce capability, partnership with patients and families, information quality and measurement. This broader framing helps explain why simply adding a reconciliation form may not reproduce an effective service. Staffing, access to pharmacy records, communication after discharge and follow-up can differ. The report’s public overview was inspected here, rather than independently appraising its entire technical evidence base.[8]
References
- MATCH toolkit introduction
Agency or professional medicine guidance
AHRQ · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official guidance passages inspected
Cited sections: Definition; comparison and prescriber resolution - Medication reconciliation and health IT
Agency or professional medicine guidance
AHRQ · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official guidance passages inspected
Cited sections: Formal process and varied implementation approaches - Medication reconciliation appendix
Agency or professional medicine guidance
AHRQ · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official guidance passages inspected
Cited sections: History, intentional changes, transfer and discharge - Create and keep a medication list for your health
Agency or professional medicine guidance
FDA · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official guidance passages inspected
Cited sections: Record fields; supplements; formats; updating and sharing - Designing the medication reconciliation process
Agency or professional medicine guidance
AHRQ · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official guidance passages inspected
Cited sections: Shared list; roles; verification and time-stamped changes - Create a safe medicine list together
Agency or professional medicine guidance
AHRQ · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected relevant original official guidance passages inspected
Cited sections: Collaborative list; duplicate use, outdated prescriptions and supplements - Impact of medication reconciliation for improving transitions of care
Systematic review
Redmond and colleagues / Cochrane · Content/publication date: 2018
Accessed: 2026-10-13 UTC · Original review summary and abstract inspected; no independent full-text appraisal
Cited sections: Original summary and abstract: trials, outcomes and certainty - Medication safety in transitions of care
Agency or professional medicine guidance
WHO · Content/publication date: 2019
Accessed: 2026-10-13 UTC · Original official technical-report overview inspected; full report not independently appraised
Cited sections: Technical-report overview: processes, workforce, partnership and information - Discharge medicines service
Official local patient service information
Guy's and St Thomas' NHS Foundation Trust · Content/publication date: not stated
Accessed: 2026-10-20 UTC · original patient information read. Whole patient-information body, enrollment, sharing, contact, review dates. No independent full evidence appraisal or qualified review completed.
Cited sections: Whole patient-information body, enrollment, sharing, contact, review dates.England hospital-service example; local arrangements need checking.
Scope & review
- Population
- General readers and caregivers; individual suitability, dosing and treatment changes require the treating professional
- Exposure or intervention
- Medication reconciliation
- Comparison
- History, current orders and discharge regimens; reconciliation interventions versus usual care in the dated review; source-specific information processes
- Outcomes
- Understanding medicine categories, formulation, safety information and care planning
- Timeframe
- Dated official guidance and selected evidence; exact product and patient context govern applicability
- Jurisdiction
- Interpret guidance within the jurisdiction, product and clinical setting identified in each cited source. Local requirements and individual medicine instructions can differ.
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
- 2026-10-20 UTC: Added bounded depth26 explanation after complete target and relevant neighboring-body audit; old section, FAQ and source objects retained exactly. Original-source access and cumulative current/pending work accounting recorded; qualified review remains pending.
What this article still leaves open
- Which service components improve clinical outcomes beyond improving list accuracy?
- How can patients reliably resolve discrepancies when several organizations hold different records?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.